/

Monte Rosa Therapeutics

Develops molecular glue degraders to treat cancer and inflammation.

BiotechnologyPharmaceuticals monterosatx.com ↗

Company facts

Founded: 2018
Employees: 150
Headquarters: United States
Type: Public
Listed: NASDAQ: GLUE